Skip to main content
SpringerLink
Log in

Pharmacokinetics of sulfadiazine and trimethoprim in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Sulfadiazine (SDZ) 800 mg and trimethoprim (TMP) 160 mg were given orally to 10 normal subjects and the concentration of SDZ and TMP in serum and urine was followed for 24 h. Both drugs showed a significant negative correlation between individual “peak” concentrations in serum and the body weight of the subject. Twelve hours after dosing the serum concentration was 12 to 25 µg/ml for SDZ and 0.3 to 1.1 µg/ml for TMP. Individual concentration ratios between SDZ and TMP in serum were 4.8 (1 h) – 145 (24 h), and in the urine the ratio was close to 6 throughout the 24 h collection period. The range of urinary concentrations was from 65 to 400 µg/ml for SDZ and from 13.8 to 93.4 µg/ml for TMP. The fraction acetylated SDZ/acetylated SDZ + SDZ was 21% during the 0–8 h period, 33% during the 8–15 h period and 41% during the 15–24 period. The average values for the notional volume of distribution, Vd, were 0.36±0.13 1/kg for SDZ and 1.39±0.25 1/kg for TMP. The average “t1/2” was 15.2±7.4 h for SDZ and 7.4±1.9 h for TMP. Individual subjects showed a significant correlation between the serum clearance of TMP and SDZ (p<0.01) and also between the renal clearance of the two drugs (p<0.05). The serum clearance was significantly correlated with the renal clearance for TMP but not for SDZ. For SDZ Vd was significantly negatively correlated with the elimination constant; for TMP no such correlation was found. The serum clearance of SDZ was significantly correlated with the percentage of SDZ which was excreted as the (presumably) acetylated compound. The renal clearance of SDZ was independent of the serum concentration of SDZ. There was a highly significant negative correlation between the renal clearance and serum concentration of TMP, as well as for “acetylated SDZ”. The renal clearance of “acetylated SDZ” averaged more than six times that of unconjugated SDZ. With increased urine flow the renal clearances of TMP and SDZ were significantly increased.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Acar, J. F., Goldstein, F., Chabbert, Y. A.: Synergistic activity of trimethoprim-sulfamethoxazole on gram-negative bacilli: Observations in vitro and in vivo. J. infect. Dis.128, S470-S477 (1973)

    Google Scholar 

  2. Bach, M. C., Finland, M., Gold, O., Wilcox, C.: Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined. J. infect. Dis.128, S508-S533 (1973a)

    Google Scholar 

  3. Bach, M. C., Gold, O., Finland, M.: Absorption and urinary excretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole. Results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole. J. infect. Dis.128, S584-S598 (1973b)

    Google Scholar 

  4. Bergan, T., Brodwall, E. K.: Kidney transport in man of sulfamethoxazole and trimethoprim. Chemotherapy17, 320–333 (1972)

    Google Scholar 

  5. Bergan, T., Vik-Mo, H., Ånstad, U.: Kinetics of a sulfadiazine-trimethoprim combination. Clin. Pharmacol. Ther.22, 211–224 (1977)

    Google Scholar 

  6. Bratton, A. C., Marshall, E. K. jr.: A new coupling component for sulfanilamide determination. J. biol. Chem.128, 537–550 (1939)

    Google Scholar 

  7. Brumfitt, W., Faiers, M. C., Pursell, R. E., Reeves, D. S., Turnbull, A. R.: Bacteriological, pharmacological and clinical studies with trimethoprim-sulphonamide combinations — with particular references to the treatment of urinary tract infections. Postgrad. med. J.45, 56–61 (1969)

    Google Scholar 

  8. Brumfitt, W., Hamilton-Miller, J. M. T., Kosmidis, J.: Trimethoprim-sulfamethoxazole: The present position. J. infect. Dis.128, S778-S791 (1973)

    Google Scholar 

  9. Bushby, S. R. M.: Trimethoprim-sulfamethoxazole: In vitro microbiological aspects. J. infect. Dis.128, S442-S462 (1973)

    Google Scholar 

  10. Craig, W. A., Kunin, C. M.: Distribution of trimethoprim-sulfamethaxazole in tissues of rhesus monkeys. J. infect. Dis.128, S575-S579 (1973)

    Google Scholar 

  11. Elsborg, L., Andreasen, F., Scherwin, J., Bülow, P.: Et nyt lavt doserbart trimethoprim-sulfonamid til langtidsbehandling af kronisk urinvejsinfektion. Ugeskr. Loeg.138, 735–738 (1976)

    Google Scholar 

  12. Kaplan, S. A., Weinfeld, R. E., Cotler, S., Abruzzo, C. W., Alexander, K.: Pharmacokinetic profile of trimethoprim in dog and man. J. Pharm. Sci.59, 358–363 (1970)

    Google Scholar 

  13. Kaplan, S. A., Weinfeld, R. E., Abruzzo, C. W., McFaden, K., Jack, M. L., Weissman, L.: Pharmacokinetic profile of trimethoprim-sulfamethoxazole in man. J. infect. Dis.128, S547-S555 (1973)

    Google Scholar 

  14. Männistö, P., Tuomisto, J., Saris, N-E., Lehtinen, T.: Pharmacokinetic studies with trimethoprim and different doses of sulfadiazine in healthy human subjects. Chemotherapy19, 289–298 (1973)

    Google Scholar 

  15. Nolte, H., Büttner, H.: Pharmacokinetics of trimethoprim and its combination with sulfamethoxazole in man after single and chronic oral administration. Chemotherapy18, 274–284 (1973)

    Google Scholar 

  16. Ohnhaus, E. E., Spring, P.: Elimination kinetics of sulfadiazine in patients with normal and impaired renal function. J. Pharmacokinet. Biopharm.3, 171–179 (1975)

    Google Scholar 

  17. Otten, H., Plempel, M., Wiegenthaler, W.: Antibiotika und Chemotherapeutika. Therapie mikrobieller Infektionen. Antibiotika-Fibel. Stuttgart: Georg Thieme Verlag 1975

  18. Richterich, R.: Klinische Chemie, pp. 341–342. Basel: Karger 1971

    Google Scholar 

  19. Rieder, J.: Quantitative determination of the bacteriostatically active fraction of sulfonamides and the sum of their inactive metabolites in the body fluids. Chemotherapy17, 1–21 (1972)

    Google Scholar 

  20. Schwartz, D. E., Ziegler, W. H.: Assay and pharmacokinetics of trimethoprim in man and animals. Postgrad. med. J.45, 32–37 (1969)

    Google Scholar 

  21. Schwartz, D. E., Koechlin, B. A., Weinfeld, R. E.: Spectrofluorometric method for the determination of trimethoprim in body fluids. Chemotherapy14, 22–29 (1969)

    Google Scholar 

  22. Schwartz, D. E., Rieder, J.: Pharmacokinetics of sulfamethoxazole + trimethoprim in man and their distribution in the rat. Chemotherapy15, 337–355 (1970)

    Google Scholar 

  23. Seydel, J. K., Wempe, E., Miller, G. H., Miller, L.: Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli. Chemotherapy17, 217–258 (1972)

    Google Scholar 

  24. Seydel, J. K., Wempe, E., Miller, G. H., Miller, L.: Quantification of the antibacterial action of trimethoprim alone and in combination with sulfonamides by bacterial growth kinetics. J. infect. Dis.128, S463-S469 (1973)

    Google Scholar 

  25. Sharpstone, P.: The renal handling of trimethoprim and sulphamethoxazole in man. Postgrad. med. J.45, 38–42 (1969)

    Google Scholar 

  26. Sigel, C. W., Grace, M. E., Nichol, C. A.: Metabolism of trimethroprim in man and measurement of a new metabolite: A new fluorescence assay. J. infect. Dis.128, S580-S583 (1973)

    Google Scholar 

  27. Tuomisto, J., Saris, N-E: Effective plasma and urine concentration of some sulfonamides and sulfonamide combinations. Ann. Med. exp. Fenn.48, 38–48 (1970)

    Google Scholar 

  28. Welling, P. G., Graig, W. A., Amidon, G. L., Kunin, C. M.: Pharmacokinetics of trimethoprim and sulfamethoxazole in normal subjects and in patients with renal failure. J. infect. Dis.128, S556-S566 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Institute of Pharmacology, University of Aarhus, Aarhus, Denmark

    F. Andreasen, L. Elsborg & S. Husted

  2. Research Department of A/S Syntetic, Aarhus, Denmark

    O. Thomsen

Authors
  1. F. Andreasen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Elsborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Husted
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Thomsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andreasen, F., Elsborg, L., Husted, S. et al. Pharmacokinetics of sulfadiazine and trimethoprim in man. Eur J Clin Pharmacol 14, 57–67 (1978). https://doi.org/10.1007/BF00560259

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00560259

Key words

Search

Navigation